MetLife Investment Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
+47,726
| New | +$244K | ﹤0.01% | 2083 |
|
|
2025
Q1 | – | Sell |
-19,631
| Closed | -$60.7K | – | 2825 |
|
|
2024
Q4 | $60.7K | Sell |
19,631
-8,633
| -31% | -$26.7K | ﹤0.01% | 2724 |
|
|
2024
Q3 | $218K | Hold |
28,264
| – | – | ﹤0.01% | 2246 |
|
|
2024
Q2 | $243K | Buy |
28,264
+2,484
| +10% | +$21.3K | ﹤0.01% | 2128 |
|
|
2024
Q1 | $205K | Hold |
25,780
| – | – | ﹤0.01% | 2193 |
|
|
2023
Q4 | $255K | Hold |
25,780
| – | – | ﹤0.01% | 2095 |
|
|
2023
Q3 | $290K | Hold |
25,780
| – | – | ﹤0.01% | 1982 |
|
|
2023
Q2 | $85.6K | Hold |
25,780
| – | – | ﹤0.01% | 2773 |
|
|
2023
Q1 | $102K | Hold |
25,780
| – | – | ﹤0.01% | 2546 |
|
|
2022
Q4 | $187K | Buy |
+25,780
| New | +$187K | ﹤0.01% | 2285 |
|
|
2022
Q3 | – | Sell |
-28,639
| Closed | -$130K | – | 2838 |
|
|
2022
Q2 | $130K | Buy |
+28,639
| New | +$130K | ﹤0.01% | 2586 |
|